Meta AnalysisID 2959
地诺前列酮、米索前列醇与单硝酸异山梨酯用于门诊宫颈成熟的有效性和安全性比较：系统评价与网状Meta分析
CRD42018107227
Which is the best treatment among used methods, including vaginal dinoprostone, intracervical dinoprostone, vaginal misoprostol, oral misoprostol and vaginal isosorbide mononitrate(IMN) for cervical ripening in outpatien
Relationship Network
Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.
Click a node to open it in a new tab
Ingredient: 1Meta-analysis: 1Links: 1
Arranging relationship network...
Record Fields
Scalar fields from the final meta_analysis record.
- Meta Analysis Id
- 2959
- Evidence Id
- 11517
- Core Evidence Id
- 11517
- Source Meta Analysis Id
- 2908
- Herb2 Meta Analysis Id
- HBMA002908
- Crd Id
- CRD42018107227
- Title
- Comparative efficacy and safety of dinoprostone, misoprostol and isosorbide mononitrate (IMN) for cervical ripening in outpatient settings: a systematic review and network meta-analysis
- Review Question
- Which is the best treatment among used methods, including vaginal dinoprostone, intracervical dinoprostone, vaginal misoprostol, oral misoprostol and vaginal isosorbide mononitrate(IMN) for cervical ripening in outpatient setting in low risk pregnant women with intact membrane?
- Study Type Included
- Randomized clinical trials.
- Condition Being Studied
- Try to find the best treatment for cervical ripening in outpatient setting.
- Participant
- Singleton fetus, cephalic presentation, 37 completed weeks gestation or more, Bishop score was no more than 6, intact membranes.
- Animal
- Human Disease Modelled
- Intervention
- Patients received either kind of cervical ripening agents with methods including vaginal dinoprostone, intracervical dinoprostone, vaginal misoprostol, oral misoprostol and vaginal isosorbide mononitrate (IMN).
- Comparator Control
- Interventions will be compared to placebo or no treatment.
- Main Outcome
- Vaginal birth not achieved within 24 hours; Additional induction agents required; Serious neonatal morbidity or perinatal death; Time from admission to delivery; Caesarean section.
- Outcome Measure
- Additional Outcome
- Uterine hyperstimulation; Apgar score <7 at 5min; NICU admission.
- Study Method
- Network meta-analysis, Systematic review
- Keyword
- Cervical Ripening; Dinoprostone; Female; Humans; Isosorbide Dinitrate; Misoprostol; Network Meta-Analysis; Outpatients; Pregnancy; isosorbide-5-mononitrate
- Contact
- Hong-bo Qi [email protected]
- Organisational Affiliation
- Department of Obstetrics, The First Affiliated Hospital of Chongqing Medical University, China http://www.hospital-cqmu.com/index.php
- Funding Source
- Other Selection Criteria
- Final Publication
- Same Topic Review
- Published Protocol
- Review Type
- Language
- Country
- China
- Review Stage
- Review Ongoing
- First Submission Date
- 2018-08-21
- Registration Date
- 2018-08-28
- Anticipated Start Date
- 2018-07-13
- Anticipated Completion Date
- 2018-12-31
- Title Cn
- 地诺前列酮、米索前列醇与单硝酸异山梨酯用于门诊宫颈成熟的有效性和安全性比较：系统评价与网状Meta分析
- Title En
- Comparative efficacy and safety of dinoprostone, misoprostol and isosorbide mononitrate (IMN) for cervical ripening in outpatient settings: a systematic review and network meta-analysis
- Bilingual Status
- complete